| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000018400 |
| Receipt No. | R000021279 |
| Official scientific title of the study | The investigation of indices representing Stress/Relax induced by Alcohol -1- |
| Date of disclosure of the study information | 2015/07/24 |
| Last modified on | 2016/07/20 (Ver. 4) |
| Basic information | ||
| Official scientific title of the study | The investigation of indices representing Stress/Relax induced by Alcohol -1- | |
| Title of the study (Brief title) | The investigation of indices representing Stress/Relax induced by Alcohol -1- | |
| Region |
|
|
| Condition | ||
| Condition | None | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To investigate the appropriate measures of relax induced by alcohol |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Subjective evaluations (General Emotion Scale, Intoxication, Sleepiness, Comfort) and physiological measures (EEG, Heart Rate, Electro Dermal Activity, Cortisol, CgA, IgA, facial expressions, breath ethanol) |
| Key secondary outcomes | |
| In outcomes field, the entry of just a few words such as "safety" or "efficiency" will not be accepted. Specify the name of outcome measures, including the time when you plan to measure. Usually, only one primary outcome is accepted. Write the other outcomes in "secondary outcomes" field. |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Cross-over |
| Randomization | Randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Placebo |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Prevention | |
| Type of intervention |
|
|
| Interventions/Control_1 | Taking alcohol->Tanking no alcohol | |
| Interventions/Control_2 | Tanking no alcohol->Taking alcohol | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| In interventions field, include the details of interventions, such as duration, amount, and frequency. If the intervention includes prescription or use of medical devices, duration is required. |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male | |||
| Key inclusion criteria | 1) BMI>=18.5 kg/m2, <25 kg/ m2
2) Non flusher |
|||
| Key exclusion criteria | 1) Person with Systolic blood pressure under 90 mmHg
2) Person with heart disease, liver disease, kidney disease 3) Person with medical history of circulatory disease 4) Person with diabetes 5) Person with drug and/or food allergy 6) Alcoholic person (KAST-M score over 4) 7) Person with depression or anxiety disorder 8) Person who the doctor assessed as improper |
|||
| Target sample size | 20 | |||
| Research contact person | |
| Name of lead principal investigator | Junichi Nakamura |
| Organization | Suntory Global Innovation Center Limited |
| Division name | Research Institute |
| Address | Suntory World Research Center 8-1-1 Seikadai, Seika-cho, Soraku-gun, Kyoto |
| TEL | 050-3182-0460 |
| Junichi_Nakamura@suntory.co.jp | |
| Public contact | |
| Name of contact person | Naoyuki Matsuzaki |
| Organization | Suntory Global Innovation Center Limited |
| Division name | Research Institute |
| Address | Suntory World Research Center 8-1-1 Seikadai, Seika-cho, Soraku-gun, Kyoto |
| TEL | 050-3182-0570 |
| Homepage URL | |
| Naoyuki_Matsuzaki@suntory.co.jp | |
| Sponsor | |
| Institute | Centan Inc. |
| Institute | |
| Department | |
| Sponsor means an organization that is responsible for plan, deployment and report of the research including funding management. It doesn't mean funding agency". Therefore, all clinical trial should have the one. |
| Funding Source | |
| Organization | Suntory Spirits Limited |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000021279 |